Nature, volume 560, issue 7717, pages 198-203
New mitochondrial DNA synthesis enables NLRP3 inflammasome activation
Zhenyu Zhong
1, 2
,
Shuang Liang
3, 4
,
Elsa Sanchez-Lopez
1, 2
,
He Feng
1, 2
,
Shabnam Shalapour
1, 2
,
Xue Jia Lin
1, 2, 5
,
JERRY WONG
1, 2
,
Siyuan Ding
6, 7, 8
,
Ekihiro Seki
9
,
Bernd Schnabl
3
,
Andrea L Hevener
10
,
Harry B. Greenberg
6, 7, 8
,
Tatiana Kisseleva
4
,
Michael Karin
1, 2
6
8
VA Palo alto Health Care System, Palo Alto, USA
|
9
Department of Medicine, Division of Gastroenterology, Cedars-Sinai Medical Center, Los Angeles, USA
|
Publication type: Journal Article
Publication date: 2018-07-25
PubMed ID:
30046112
Multidisciplinary
Abstract
Dysregulated NLRP3 inflammasome activity results in uncontrolled inflammation, which underlies many chronic diseases. Although mitochondrial damage is needed for the assembly and activation of the NLRP3 inflammasome, it is unclear how macrophages are able to respond to structurally diverse inflammasome-activating stimuli. Here we show that the synthesis of mitochondrial DNA (mtDNA), induced after the engagement of Toll-like receptors, is crucial for NLRP3 signalling. Toll-like receptors signal via the MyD88 and TRIF adaptors to trigger IRF1-dependent transcription of CMPK2, a rate-limiting enzyme that supplies deoxyribonucleotides for mtDNA synthesis. CMPK2-dependent mtDNA synthesis is necessary for the production of oxidized mtDNA fragments after exposure to NLRP3 activators. Cytosolic oxidized mtDNA associates with the NLRP3 inflammasome complex and is required for its activation. The dependence on CMPK2 catalytic activity provides opportunities for more effective control of NLRP3 inflammasome-associated diseases. New mitochondrial DNA synthesis links the priming and activation of the NLRP3 inflammasome.
Are you a researcher?
Create a profile to get free access to personal recommendations for colleagues and new articles.